July 22, 2013 — Vizzia Technologies announced that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists and Research Institute's (FCS) Tampa Cancer Center location. The newly constructed 35,990 square foot flagship facility offers a "one-stop" approach to patient care that includes medical oncology, advanced radiation oncology technology and radiological services for identifying and diagnosing tumors. The Vizzia solution, which leverages CenTrak's Clinical-Grade RTLS, is designed to transform the outpatient experience and help in optimizing patient flow processes. Shortening patient wait times and ensuring patient safety and satisfaction, as well as increasing the cancer center's patient treatment capacity are among the benefits of the new solution.

"Cancer treatment can be a daunting challenge for many of our patients. We are proud to have installed the latest technologies to enhance our patients' experiences at our center. Vizzia's advanced workflow solution allows us the visibility and data we need to accelerate the overall treatment process, so our patients can more quickly return to their normal routines," said Todd Schonherz, Florida Cancer Specialists' chief operating officer.

Vizzia integrated its Web-based information portal with the CenTrak Clinical-Grade Locating infrastructure. Their Vizzion Suite software automatically updates the location of patients and staff from CenTrak's RTLS and incorporates important workflow rules and alerts to ensure that patients move through the treatment process as efficiently as possible. The Clinical-Grade RTLS platform uses battery-operated Gen2IR and Virtual Wall devices to deliver unmatched room-, bed-, and bay-level accuracy. The advanced technology delivers rapid location update speeds and offers small, full-featured tags with extremely long battery life.

For more information: www.vizziatech.com.

Related Content

News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
News | Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

Time August 04, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
Feature | Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

Time August 01, 2022
arrow
Subscribe Now